Madrigal Pharmaceuticals, Inc.
MDGLNasdaqCIK 1157601HealthcareFiscal year ends Dec 31
Reports and events: 319 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1208:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-055962 |
| 2026-07-3009:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-050845 |
| 2026-07-3007:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-050775 |
| 2026-06-1716:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-075130 |
| 2026-05-0609:04 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-030947 |
| 2026-05-0607:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030896 |
| 2026-04-2816:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-027956 |
| 2026-04-2816:05 ET | DEF 14A | Proxy statementPeriod 2026-06-17 | 0001308179-26-000352 |
| 2026-02-1909:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-009514 |
| 2026-02-1907:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-009476 |
| 2026-01-3017:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-008698 |
| 2025-12-1218:10 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-120744 |
| 2025-12-1218:10 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-120743 |
| 2025-12-1116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-056533 |
| 2025-11-0409:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-048559 |
| 2025-11-0407:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-048525 |
| 2025-08-0508:59 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-037613 |
| 2025-08-0507:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-037596 |
| 2025-07-3006:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-071928 |
| 2025-07-2208:29 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-035506 |
| 2025-06-2016:04 ET | 8-K | 5.07 Shareholder vote results | 0001628280-25-032358 |
| 2025-05-0108:53 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-021356 |
| 2025-05-0107:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-021314 |
| 2025-04-2916:16 ET | DEF 14A | Proxy statementPeriod 2025-06-20 | 0001104659-25-041254 |
| 2025-04-1716:52 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-018242 |
| 2025-03-1108:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-051461 |
| 2025-02-2609:09 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-007980 |
| 2025-02-2607:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-035787 |
| 2025-01-1306:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-004939 |
| 2024-10-3109:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-044445 |
| 2024-10-3107:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-248137 |
| 2024-08-0708:58 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-035400 |
| 2024-08-0707:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-195400 |
| 2024-06-2716:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-170634 |
| 2024-05-0716:36 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-133196 |
| 2024-05-0709:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-020865 |
| 2024-05-0707:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-132559 |
| 2024-04-2916:49 ET | DEF 14A | Proxy statementPeriod 2024-06-25 | 0001193125-24-122657 |
| 2024-04-0216:31 ET | 8-K | 8.01 Other events | 0001193125-24-084797 |
| 2024-03-2516:28 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-038465 |
| 2024-03-2016:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-072706 |
| 2024-03-1518:47 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-068170 |
| 2024-02-2807:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-049136 |
| 2024-02-2807:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-049116 |
| 2024-02-2806:32 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-007376 |
| 2024-01-0813:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-004269 |
| 2023-12-1316:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-294326 |
| 2023-11-2117:24 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-120429 |
| 2023-11-0608:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-270884 |
| 2023-11-0606:10 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001193125-23-270803 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.